Order Requiring Patent To Be Delisted Affirmed On Appeal To Federal Circuit
WASHINGTON, D.C. — A federal judge in Delaware did not abuse his discretion in directing a patent owner to delist its patent from the U.S. Food and Drug Administration’s Approved Drug...To view the full article, register now.
Already a subscriber? Click here to view full article